Copyright: ©Author(s) 2026.
World J Gastrointest Oncol. Aug 15, 2026; 18(8): 120942
Published online Aug 15, 2026. doi: 10.4251/wjgo.120942
Published online Aug 15, 2026. doi: 10.4251/wjgo.120942
Figure 4 Receiver operating characteristic analysis of preoperative TP53 circulating tumor DNA for lymph node metastasis prediction.
The analysis yields an area under the curve of 0.704, indicating the potential of TP53 circulating tumor DNA variant allele frequency as a predictive biomarker for nodal metastasis. AUC: Area under the curve; CI: Confidence interval.
- Citation: Gu RT, Liu T, Piao ZS, Jin H, Wang XW, Li X. Quantitative TP53 circulating tumor DNA predicts tumor response and survival outcomes in esophageal squamous cell carcinoma. World J Gastrointest Oncol 2026; 18(8): 120942
- URL: https://www.wjgnet.com/1948-5204/full/v18/i8/120942.htm
- DOI: https://dx.doi.org/10.4251/wjgo.120942